{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:46:10Z","timestamp":1762177570308},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The 2019 guidelines for cardiovascular risk stratification by the European Society of Cardiology and European Association for the Study of Diabetes (ESC-EASD) suggested screening for silent coronary disease in very high risk patients with severe target organ damage (TOD) (i.e. peripheral occlusive arterial disease or severe nephropathy) or high coronary artery calcium (CAC) score. This study aimed to test the validity of this strategy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective study, we included 385 asymptomatic patients with diabetes and no history of coronary disease but with TOD or\u2009\u2265\u20093 risk factors in addition to diabetes. CAC score was measured using computed tomography scan and a stress myocardial scintigraphy was performed to detect silent myocardial ischemia (SMI), with subsequent coronary angiography in those with SMI. Various strategies to select patients to be screened for SMI were tested.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CAC score was\u2009\u2265\u2009100 Agatston units (AU) in 175 patients (45.5%). SMI was present in 39 patients (10.1%) and among the 30 patients who underwent angiography, 15 had coronary stenoses and 12 had a revascularization procedure. The most effective strategy consisted in performing myocardial scintigraphy in the 146 patients with severe TOD and, among the 239 other patients without severe TOD, in those with CAC\u2009\u2265\u2009100 AU: this strategy provided 82% sensitivity for SMI diagnosis, and identified all the patients with stenoses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The ESC-EASD guidelines suggesting SMI screening in asymptomatic patients with very high risk assessed by severe TOD or high CAC score appears effective and could identify all the patients with stenoses eligible for revascularization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01760-4","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T11:51:59Z","timestamp":1676980319000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Performance of the 2019 ESC\/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes"],"prefix":"10.1186","volume":"22","author":[{"given":"Paul","family":"Valensi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narimane","family":"Berkane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Sellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Soussan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh Tuan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Cosson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"1760_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, et al. ESC scientific document group. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255\u2013323. https:\/\/doi.org\/10.1093\/eurheartj\/ehz486.","journal-title":"Eur Heart J."},{"key":"1760_CR2","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.jacc.2003.09.068","volume":"43","author":"P Raggi","year":"2004","unstructured":"Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43:1663\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2003.09.068.","journal-title":"J Am Coll Cardiol"},{"key":"1760_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","volume":"72","author":"P Greenland","year":"2018","unstructured":"Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol. 2018;72:434\u201347. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.027.","journal-title":"J Am Coll Cardiol"},{"key":"1760_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1654","author":"CK Kramer","year":"2013","unstructured":"Kramer CK, Zinman B, Gross JL, et al. Coronary artery calcium score prediction of all-cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis. BMJ. 2013. https:\/\/doi.org\/10.1136\/bmj.f1654.","journal-title":"BMJ"},{"key":"1760_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jcmg.2015.11.023","volume":"9","author":"C Bavishi","year":"2016","unstructured":"Bavishi C, Argulian E, Chatterjee S, Rozanski A. CACS and the frequency of stress-induced myocardial ischemia during MPI: a meta-analysis. JACC Cardiovasc Imaging. 2016;9:580\u20139. https:\/\/doi.org\/10.1016\/j.jcmg.2015.11.023.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1760_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/eurheartj\/ehi808","volume":"27","author":"DV Anand","year":"2006","unstructured":"Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006;27:713\u201321. https:\/\/doi.org\/10.1093\/eurheartj\/ehi808.","journal-title":"Eur Heart J"},{"key":"1760_CR7","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.2337\/diacare.28.11.2722","volume":"28","author":"P Valensi","year":"2005","unstructured":"Valensi P, Pari\u00e8s J, Brulport-Cerisier V, et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care. 2005;28:2722\u20137. https:\/\/doi.org\/10.2337\/diacare.28.11.2722.","journal-title":"Diabetes Care"},{"key":"1760_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1475-2840-13-20","volume":"13","author":"MT Nguyen","year":"2014","unstructured":"Nguyen MT, Pham I, Valensi P, et al. Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients. Cardiovasc Diabetol. 2014;13:20. https:\/\/doi.org\/10.1186\/1475-2840-13-20.","journal-title":"Cardiovasc Diabetol"},{"key":"1760_CR9","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/dme.13364","volume":"34","author":"A Sultan","year":"2017","unstructured":"Sultan A, Perriard F, Macioce V, et al. Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in type 2 diabetes over a 10-year period: an observational study. Diabet Med. 2017;34:1244\u201351. https:\/\/doi.org\/10.1111\/dme.13364.","journal-title":"Diabet Med"},{"key":"1760_CR10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/ehjci\/jey014","volume":"19","author":"OF Clerc","year":"2018","unstructured":"Clerc OF, Fuchs TA, Stehli J, et al. Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials. Eur Heart J Cardiovasc Imaging. 2018;19:838\u201346. https:\/\/doi.org\/10.1093\/ehjci\/jey014.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1760_CR11","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.2337\/dc11-0480","volume":"34","author":"E Cosson","year":"2011","unstructured":"Cosson E, Nguyen MT, Chanu B, et al. Cardiovascular risk prediction is improved by adding asymptomatic coronary status to routine risk assessment in type 2 diabetic patients. Diabetes Care. 2011;34:2101\u20137. https:\/\/doi.org\/10.2337\/dc11-0480.","journal-title":"Diabetes Care"},{"key":"1760_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-t","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. JACC. 1990;15:827\u201332. https:\/\/doi.org\/10.1016\/0735-1097(90)90282-t.","journal-title":"JACC"},{"key":"1760_CR13","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","volume":"370","author":"EW Gregg","year":"2014","unstructured":"Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990\u20132010. N Engl J Med. 2014;370:1514\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1310799.","journal-title":"N Engl J Med"},{"key":"1760_CR14","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376:1407\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1608664.","journal-title":"N Engl J Med"},{"key":"1760_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/bmj.39582.447998.BE","volume":"337","author":"AC Dale","year":"2008","unstructured":"Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ. 2008;337:236. https:\/\/doi.org\/10.1136\/bmj.39582.447998.BE.","journal-title":"BMJ"},{"key":"1760_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.amjcard.2012.11.042","volume":"111","author":"YB Pride","year":"2013","unstructured":"Pride YB, Piccirillo BJ, Gibson CM. Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction. Am J Cardiol. 2013;111:914\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2012.11.042.","journal-title":"Am J Cardiol"},{"key":"1760_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.acvd.2018.04.008","volume":"112","author":"G Rang\u00e9","year":"2019","unstructured":"Rang\u00e9 G, Saint Etienne C, Marcollet P, et al. Factors associated with delay in transfer of patients with ST-segment elevation myocardial infarction from first medical contact to catheterization laboratory: lessons from CRAC, a French prospective multicentre registry. Arch Cardiovasc Dis. 2019;112:3\u201311. https:\/\/doi.org\/10.1016\/j.acvd.2018.04.008.","journal-title":"Arch Cardiovasc Dis"},{"key":"1760_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.acvd.2010.11.013","volume":"104","author":"P Valensi","year":"2011","unstructured":"Valensi P, Lorgis L, Cottin Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis. 2011;104:178\u201388. https:\/\/doi.org\/10.1016\/j.acvd.2010.11.013.","journal-title":"Arch Cardiovasc Dis"},{"key":"1760_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/s0002-9149(96)00699-6","volume":"79","author":"Milan Study on Atherosclerosis and Diabetes (MiSAD) Group","year":"1997","unstructured":"Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol. 1997;79:134\u20139. https:\/\/doi.org\/10.1016\/s0002-9149(96)00699-6.","journal-title":"Am J Cardiol"},{"key":"1760_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1464-5491.2004.01157.x","volume":"21","author":"E Cosson","year":"2004","unstructured":"Cosson E, Paycha F, Paries J, et al. Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy? Diabet Med. 2004;21:342\u20138. https:\/\/doi.org\/10.1111\/j.1464-5491.2004.01157.x.","journal-title":"Diabet Med"},{"key":"1760_CR21","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/j.1464-5491.2006.01992.x","volume":"23","author":"S Sejil","year":"2006","unstructured":"Sejil S, Janand-Delenne B, Avierinos JF, et al. Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia. Diabet Med. 2006;23:1186\u201391. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01992.x.","journal-title":"Diabet Med"},{"key":"1760_CR22","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.2337\/diabetes.50.5.1180","volume":"50","author":"A Nitenberg","year":"2001","unstructured":"Nitenberg A, Ledoux S, Valensi P, Sachs R, Attali JR, Antony I. Impairment of coronary microvascular dilation in response to cold pressor\u2013induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. Diabetes. 2001;50:1180\u20135. https:\/\/doi.org\/10.2337\/diabetes.50.5.1180.","journal-title":"Diabetes"},{"key":"1760_CR23","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2337\/diab.42.7.1017","volume":"42","author":"A Nitenberg","year":"1993","unstructured":"Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 1993;42:1017\u201325. https:\/\/doi.org\/10.2337\/diab.42.7.1017.","journal-title":"Diabetes"},{"key":"1760_CR24","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1001\/jama.2014.15825","volume":"312","author":"JB Muhlestein","year":"2014","unstructured":"Muhlestein JB, Lapp\u00e9 DL, Lima JA, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA. 2014;312:2234\u201343. https:\/\/doi.org\/10.1001\/jama.2014.15825.","journal-title":"JAMA"},{"key":"1760_CR25","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2009.476","volume":"301","author":"LH Young","year":"2009","unstructured":"Young LH, Wackers FJ, Chyun DA, et al. DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301:1547\u201355. https:\/\/doi.org\/10.1001\/jama.2009.476.","journal-title":"JAMA."},{"key":"1760_CR26","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.jacc.2009.05.071","volume":"54","author":"SM Chang","year":"2009","unstructured":"Chang SM, Nabi F, Xu J, et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol. 2009;54:1872\u201382. https:\/\/doi.org\/10.1016\/j.jacc.2009.05.071.","journal-title":"J Am Coll Cardiol"},{"key":"1760_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.diabet.2010.01.001","volume":"36","author":"P Valensi","year":"2010","unstructured":"Valensi P, Cosson E. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes Metab. 2010;36:91\u20136. https:\/\/doi.org\/10.1016\/j.diabet.2010.01.001.","journal-title":"Diabetes Metab"},{"key":"1760_CR28","doi-asserted-by":"publisher","first-page":"107947","DOI":"10.1016\/j.diabres.2019.107947","volume":"159","author":"P Valensi","year":"2020","unstructured":"Valensi P, Pr\u00e9vost G. CVOTs: what did the endocrinologist learn. Diabetes Res Clin Pract. 2020;159:107947. https:\/\/doi.org\/10.1016\/j.diabres.2019.107947.","journal-title":"Diabetes Res Clin Pract"},{"key":"1760_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00125-019-05039-w","volume":"63","author":"JB Buse","year":"2020","unstructured":"Buse JB, Wexler DJ, Tsapas A, et al. Management of hyperglycaemia in type 2 diabetes, 2018 a consensus report by the american diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetologia. 2020;63:221\u20138. https:\/\/doi.org\/10.1007\/s00125-019-05039-w.","journal-title":"Diabetologia"},{"key":"1760_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.echo.2021.10.013","volume":"35","author":"G Albenque","year":"2022","unstructured":"Albenque G, Rusinaru D, Bellaiche M, Di Lena C, Gabrion P, Delpierre Q, Malaquin D, Tribouilloy C, Bohbot Y. Resting left ventricular global longitudinal strain to identify silent myocardial ischemia in asymptomatic patients with diabetes mellitus. J Am Soc Echocardiogr. 2022;35:258\u201366. https:\/\/doi.org\/10.1016\/j.echo.2021.10.013.","journal-title":"J Am Soc Echocardiogr"},{"key":"1760_CR31","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.ijcha.2021.100829","volume":"35","author":"S Ikeda","year":"2021","unstructured":"Ikeda S, Sato K, Takeda M, Miki K, Aizawa K, Takada T, Fukuda K, Shiba N. Oncostatin M is a novel biomarker for coronary artery disease\u2014a possibility as a screening tool of silent myocardial ischemia for diabetes mellitus. Int J Cardiol Heart Vasc. 2021;35:100829. https:\/\/doi.org\/10.1016\/j.ijcha.2021.100829.","journal-title":"Int J Cardiol Heart Vasc."},{"key":"1760_CR32","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S010","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. 10 cardiovascular disease and risk management: standards of medical care in diabetes-2021. Diabetes Care. 2021. https:\/\/doi.org\/10.2337\/dc21-S010.","journal-title":"Diabetes Care"},{"key":"1760_CR33","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.2337\/diacare.22.9.1396","volume":"22","author":"B Janand-Delenne","year":"1999","unstructured":"Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care. 1999;22:1396\u2013400. https:\/\/doi.org\/10.2337\/diacare.22.9.1396.","journal-title":"Diabetes Care"},{"key":"1760_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1161\/01.CIR.0000133278.81226.C9","volume":"110","author":"C Gazzaruso","year":"2004","unstructured":"Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004;110:22\u20136. https:\/\/doi.org\/10.1161\/01.CIR.0000133278.81226.C9.","journal-title":"Circulation"},{"key":"1760_CR35","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","volume":"26","author":"AI Vinik","year":"2003","unstructured":"Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553\u201379. https:\/\/doi.org\/10.2337\/diacare.26.5.1553.","journal-title":"Diabetes Care"},{"key":"1760_CR36","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1681\/ASN.2008121270","volume":"20","author":"T Ninomiya","year":"2009","unstructured":"Ninomiya T, Perkovic V, de Galan BE, et al. ADVANCE collaborative group. albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20:1813\u201321. https:\/\/doi.org\/10.1681\/ASN.2008121270.","journal-title":"J Am Soc Nephrol."},{"key":"1760_CR37","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jcmg.2010.06.001","volume":"3","author":"A Hakeem","year":"2010","unstructured":"Hakeem A, Bhatti S, Karmali KN, et al. Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease. JACC Cardiovasc Imaging. 2010;3:734\u201345. https:\/\/doi.org\/10.1016\/j.jcmg.2010.06.001.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1760_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2174\/1573403x10666140214122234","volume":"9","author":"Q Cai","year":"2013","unstructured":"Cai Q, Mukku VK, Ahmad M. Coronary artery disease in patients with chronic kidney disease: a clinical update. Curr Cardiol Rev. 2013;9:331\u20139. https:\/\/doi.org\/10.2174\/1573403x10666140214122234.","journal-title":"Curr Cardiol Rev"},{"key":"1760_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00125-004-1640-z","volume":"48","author":"PD Reaven","year":"2005","unstructured":"Reaven PD, Sacks J. Investigators for the VADT coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes. Diabetologia. 2005;48:379\u201385. https:\/\/doi.org\/10.1007\/s00125-004-1640-z.","journal-title":"Diabetologia."},{"key":"1760_CR40","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamacardio.2017.4191","volume":"2","author":"S Malik","year":"2017","unstructured":"Malik S, Zhao Y, Budoff M, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis. JAMA Cardiol. 2017;2:1332\u201340. https:\/\/doi.org\/10.1001\/jamacardio.2017.4191.","journal-title":"JAMA Cardiol"},{"key":"1760_CR41","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.jacc.2006.10.079","volume":"49","author":"MJ Budoff","year":"2007","unstructured":"Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49:1860\u201370. https:\/\/doi.org\/10.1016\/j.jacc.2006.10.079.","journal-title":"J Am Coll Cardiol"},{"key":"1760_CR42","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ahj.2007.02.020","volume":"153","author":"G Ramakrishna","year":"2007","unstructured":"Ramakrishna G, Miller TD, Breen JF, Araoz PA, Hodge DO, Gibbons RJ. Relationship and prognostic value of coronary artery calcification by electron beam computed tomography to stress-induced ischemia by single photon emission computed tomography. Am Heart J. 2007;153:807\u201314. https:\/\/doi.org\/10.1016\/j.ahj.2007.02.020.","journal-title":"Am Heart J"},{"key":"1760_CR43","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jacc.2011.01.019","volume":"57","author":"A Rozanski","year":"2011","unstructured":"Rozanski A, Gransar H, Shaw LJ, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of subclinical atherosclerosis by noninvasive imaging research) prospective randomized trial. J Am Coll Cardiol. 2011;57:1622\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2011.01.019.","journal-title":"J Am Coll Cardiol"},{"key":"1760_CR44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.nuclcard.2007.04.011","volume":"14","author":"E Lim","year":"2007","unstructured":"Lim E, Lahiri A. The importance of the link between coronary artery calcification and myocardial ischemia: a developing argument. J Nucl Cardiol. 2007;14:272\u20134. https:\/\/doi.org\/10.1016\/j.nuclcard.2007.04.011.","journal-title":"J Nucl Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01760-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01760-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T11:52:01Z","timestamp":1676980321000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01760-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01760-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"assertion":[{"value":"8 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not needed for this observational study. In Jean Verdier hospital and in general in the various Public Assistance Hospitals in Paris, all patients are informed at admission that their medical records may be used for research, unless they indicate their opposition. For the present study, no patient indicated opposition. Data were analyzed anonymously.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PV discloses the following potential conflicts of interest: lectures for Abbott, AstraZeneca, Bayer, Eli Lilly, Hikma Pharmaceuticals, Merck Sharp & Dohme, Novo Nordisk, Novartis, Pfizer, Sanofi, Servier; research grants from Abbott, Bristol-Myers Squibb\u2013AstraZeneca, Novo Nordisk; participation in expert committees for AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Daiichi Sankyo, Sanofi, Servier. EC discloses the following potential conflicts of interest: lectures for Abbott, AstraZeneca, Eli Lilly, Novo Nordisk, Novartis, Sanofi; research grants from Abbott, Air Liquide, AstraZeneca, LVL medical, Medtronic, Novo Nordisk, Sanofi;\u00a0participation in expert committees for AstraZeneca, Medtronic, Novo Nordisk, Sanofi.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}